Actively Recruiting
Real-world Clinical Outcomes of Patients With Early-stage Lung Cancer After the Surgery
Led by Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Updated on 2025-08-29
20000
Participants Needed
1
Research Sites
561 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this observational study is to evaluate the efficacy and long-term clinical outcomes of early-stage lung cancer patients who have received surgery using the real-world data. The main questions it aims to answer are: * What is the best surgical strategy for patients with early-stage lung cancer? * What are the risk factors for early-stage lung cancer? Participants will receive surgery and the study will analyze the real-world data.
CONDITIONS
Official Title
Real-world Clinical Outcomes of Patients With Early-stage Lung Cancer After the Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged between 18 and 85
- Have not received neoadjuvant therapy before surgery
- No history of radiation therapy
- Eastern Cooperative Oncology Group (ECOG) score of 0-1
- Have complete clinically relevant information including imaging data
- Underwent all relevant preoperative examinations
- Diagnosed with stage I lung cancer according to the eighth edition staging system
You will not qualify if you...
- Previously received chemotherapy, radiotherapy, or other anti-tumor therapies
- Have data loss or errors in medical records due to human or objective reasons
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Shugeng Gao
Beijing, Beijing Municipality, China, 100020
Actively Recruiting
Research Team
S
Shugeng Gao, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here